Andexanet Alfa and 4F-PCC Use in Patients Hospitalised With an Anticoagulant-related Major Bleed

Clinical trial NCT05548777 · COMPLETED

Trial details

NCT number: NCT05548777
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Anticoagulant-related Major Bleed

Start date: 2022-09-15
Primary completion: 2022-12-20
Enrollment: 5480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.